Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Revenue (2016 - 2025)

INVO Fertility (IVF) has disclosed Revenue for 15 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • Quarterly Revenue rose 22.6% to $1.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.9 million through Sep 2025, up 11.5% year-over-year, with the annual reading at $6.5 million for FY2024, 116.25% up from the prior year.
  • Revenue for Q3 2025 was $1.8 million at INVO Fertility, down from $1.9 million in the prior quarter.
  • The five-year high for Revenue was $3.0 million in Q4 2021, with the low at $146135.0 in Q2 2022.
  • Average Revenue over 5 years is $1.0 million, with a median of $974894.0 recorded in 2023.
  • The sharpest move saw Revenue surged 1450.7% in 2021, then tumbled 90.88% in 2022.
  • Over 5 years, Revenue stood at $3.0 million in 2021, then crashed by 90.88% to $278142.0 in 2022, then surged by 396.78% to $1.4 million in 2023, then grew by 22.02% to $1.7 million in 2024, then increased by 4.22% to $1.8 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $1.8 million, $1.9 million, and $1.6 million for Q3 2025, Q2 2025, and Q1 2025 respectively.